Award Data

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop an antimicrobial muscle-regenerating biomaterial into a commercial-ready product and address volumetric muscle loss injuries. In the context of defense medicine, severe muscle trauma often occurs in environments where external factors such as sterility are not well-controlled. Th ...

The broader impact of this Small Business Innovation Research (SBIR) Phase I project will be to develop methods to facilitate the efficient, reproducible insertion of large DNA segments into stable locations on bacterial vectors, viral and non-viral shuttle vectors, and the chromosomes of prokaryotic and eukaryotic host cells comprising novel target sequences plus helper and donor vectors that cou ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project lies in enhancing health outcomes and quality of life for cancer patients. Each year, over 1.7 million Americans are diagnosed with cancer, and treatment turns out to be ineffective for approximately 75% of those receiving systemic therapy. This failure is because every tumor is distinct in ma ...

The broader impact of this Small Business Innovation Research (SBIR) Phase I project is the potential reduction of toxic nitrogen oxides (NOx) and harmful carbon dioxide (CO2) emissions from marine diesel engines. There are approximately 4 million diesel-powered craft in use globally, emitting approximately one billion tons of CO2 and 100 million tons of NOx annually. This project seeks to remove ...

This SBIR Phase I project will develop a machine learning-assisted family math preparation program that will help and encourage parents to provide early math instruction to young children, ages 4-8. Along with reading, developing mathematical proficiency is arguably one of the most important skills for young children to acquire, particularly with the growing importance of STEM (science, technology ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will provide a tool for vascular imaging, an area of medicine with a large clinical need. The developed blood pool contrast agent (BPCA) has the potential to disrupt the current magnetic resonance angiography (MRA) contrast agent market because of its improved safety profile and enhanced imag ...

The broader/commercial impact of this Small Business Technology Transfer (STTR) Phase I project is a tool to help mitigate the wildfire crisis in the western United States. Prescribed burns are one of the most effective ways to prevent the uncontrolled, large-scale wildfires that devastate entire ecosystems, communities, and economies, but the environmental assessment required for burns may delay ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is in helping in the design of a cost-effective resiliency strategy for defense against the impacts of climate change. Today, the U.S. experiences significantly more weather events imposing substantially more financial burden compared to 40 years ago. As climate change accelerates, communities ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to design a care-centered digital health platform for remote symptom monitoring of Parkinson’s Disease patients. Parkinson’s is a progressive neurological disorder affecting various movement and mobility, sleep quality, emotional and behavioral health, and other factors, with symptoms m ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is the commercialization of an aqueous lithium and zinc ion battery that is a replacement for lead-acid and lithium-ion batteries in stationary energy storage applications.This battery has a nonflammable, environmentally-friendly, water-based electrolyte and does not utilize cobalt or nickel, reducing ...